Softhale is a medical device startup founded in 2016 with the slogan "Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices". The company is focused on the development of Soft Mist Inhalation (SMI) devices for the delivery of pharmaceutical drugs to the lungs, operating in the Biotechnology and Health Care industries. Softhale received its Series A investment from New Rhein Healthcare Investors on 30 November 2016. As a company specializing in medical device innovation, Softhale represents a promising investment opportunity in the rapidly evolving healthcare sector with its advanced drug delivery technology.
Softhale
Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices
Founded 2016
Series A
Biotechnology, Health Care +1
General Information
Company Name
Softhale
Founded Year
2016
Industries
Biotechnology, Health Care, Medical Devices
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with Softhale. To contact Softhale, visit softhale.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Softhale compare?
A PDF of Softhale and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Softhale soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Softhale
Business keywords: lung drug delivery, medical device company, Soft Mist Inhalation, pharmaceutical drugs, inhalation devices, drug delivery, respiratory medicine, innovation, pulmonary drug delivery, drug administration
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | Undisclosed | 1 |
|
30 Nov 2016 |
Softhale Alternatives & Competitors
View All Alternatives
Softhale vs
Pioneering advanced respiratory drug delivery solutions for asthma and chronic obstructive pulmonary...
Series D
Biotechnology, Health Care
Softhale vs
Advancing the Safety and Precision of Injectable Drug Delivery Through Innovative Technology
Non Equity Assistance
1 employees
Health Care, Medical Devices
Softhale vs
Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...
Series B
Biotechnology, Health Care
Breath Therapeutics
FAQ About Softhale
Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices
Softhale was founded in 2016.
Softhale operates in Biotechnology, Health Care and Medical Devices. Its work centres on lung drug delivery, medical device company, Soft Mist Inhalation and pharmaceutical drugs.
Softhale has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to Softhale include OMNI, Crisi Medical Systems, Bostal Drug Delivery, Breath Therapeutics, SkyX Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Softhale and OMNI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Softhale, https://bouncewatch.com/company/softhale, updated 10 October 2024. When citing, please name BounceWatch and link this page.
